Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online February 23, 2012.
Article Versions
- You are currently viewing a previous version of this article (February 23, 2012 - 06:07).
- View the most recent version of this article
Copyright & Usage
ERS
Author Information
- W-J. Zeng*,§,
- C-M. Xiong*,§,
- L. Zhao¶§,
- G-L. Shan#,
- Z-H. Liu*,
- F. Xue#,
- Q. Gu*,
- X-H. Ni*,
- Z-H. Zhao*,
- X-S. Cheng*,
- M.R. Wilkins¶⇓,
- J-G. He*⇓ and
- on behalf of the Atorvastatin in Pulmonary Arterial Hypertension (APATH) Study Group+
- *Pulmonary Vascular Disease Center, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
- #Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, China
- ¶Experimental Medicine, Imperial College London, Hammersmith Hospital, Ducane Road, London W12 ONN, UK
- +Study Group participants are listed in the acknowledgements
- §contributed equally as first authors to this manuscript
- M.R. Wilkins, Experimental Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0NN, E-mail: m.wilkins{at}imperial.ac.uk
- J-G. He, Pulmonary Vascular Diseases Center, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 167 Beilishi Road, Xicheng District, Beijing, 100037, China, E-mail:hejianguofw{at}gmail.com
Article usage
Altmetrics
Vol 62 Issue 3
Table of Contents
Atorvastatin in pulmonary hypertension (apath) study
